Literature DB >> 2833921

Macrophages in human breast disease: a quantitative immunohistochemical study.

P M Kelly1, R S Davison, E Bliss, J O McGee.   

Abstract

We describe a quantitative histological study of 34 breast biopsies using a marker for human macrophages, the monoclonal antibody EBM/11. Seventeen of the biopsies were of malignant tumours. Both benign and malignant breast tissue contained large numbers of macrophages with significantly higher numbers occurring in the malignant group. An analysis was made of macrophage counts according to stage, grade and prognostic index of the malignant tumours. There was no correlation between macrophage numbers and any of these parameters in malignant breast tumours. We discuss the possible reasons why some earlier studies (using other markers such as lysozyme), have shown an apparently insignificant number of intratumoral macrophages.

Entities:  

Mesh:

Year:  1988        PMID: 2833921      PMCID: PMC2246436          DOI: 10.1038/bjc.1988.36

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Macrophage infiltration of breast tumours: a prospective study.

Authors:  I Lauder; W Aherne; J Stewart; R Sainsbury
Journal:  J Clin Pathol       Date:  1977-06       Impact factor: 3.411

2.  Immunofluorescent localization of alpha-1-antitrypsin in human polymorphonuclear leukocytes.

Authors:  L Benítez-Bribiesca; R Freyre-Horta
Journal:  Life Sci       Date:  1978-01       Impact factor: 5.037

3.  Immunohistochemical study on the distribution and significance of mononuclear cells in human breast carcinoma.

Authors:  H Tanaka; T Shimoda; K Uchida; T Suzuki; E Ishikawa
Journal:  Acta Pathol Jpn       Date:  1986-10

4.  Studies on the role of macrophages in regulation of growth and metastasis of murine chemically induced fibrosarcomas.

Authors:  G W Wood; G Y Gillespie
Journal:  Int J Cancer       Date:  1975-12-15       Impact factor: 7.396

5.  Expression of monocytic--histiocytic cytochemical markers in epithelial neoplasia.

Authors:  R R Tubbs; R A Savage; R H Crabtree; B A Sebek; R Valenzuela; S P Benjamin
Journal:  Am J Clin Pathol       Date:  1979-11       Impact factor: 2.493

6.  Production of a tumor cytolytic factor(s) by activated human alveolar macrophages and its action.

Authors:  S Sone; K Tachibana; K Ishii; M Ogawara; E Tsubura
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

7.  Alpha-1-antitrypsin in human macrophages.

Authors:  P Isaacson; D B Jones; G H Millward-Sadler; M A Judd; S Payne
Journal:  J Clin Pathol       Date:  1981-09       Impact factor: 3.411

8.  Lysozyme in human gastric carcinoma: a retrospective immunohistochemical study.

Authors:  E Tahara; H Ito; F Shimamoto; T Iwamoto; K Nakagami; H Niimoto
Journal:  Histopathology       Date:  1982-07       Impact factor: 5.087

9.  Possible host resistance in carcinoma of the breast: a histological study.

Authors:  I M Hamlin
Journal:  Br J Cancer       Date:  1968-09       Impact factor: 7.640

10.  A prognostic index in primary breast cancer.

Authors:  J L Haybittle; R W Blamey; C W Elston; J Johnson; P J Doyle; F C Campbell; R I Nicholson; K Griffiths
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640

View more
  46 in total

Review 1.  The macrophage growth factor CSF-1 in mammary gland development and tumor progression.

Authors:  Elaine Y Lin; Valerie Gouon-Evans; Andrew V Nguyen; Jeffrey W Pollard
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

2.  Labelling of cells of the mononuclear phagocyte system in routinely processed archival biopsy specimens with monoclonal antibody EBM/11.

Authors:  G I Greywoode; S P McCarthy; J O McGee
Journal:  J Clin Pathol       Date:  1990-12       Impact factor: 3.411

Review 3.  Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers.

Authors:  Sarah C Baumgarten; Jonna Frasor
Journal:  Mol Endocrinol       Date:  2012-02-02

4.  High macrophage PD-L1 expression not responsible for T cell suppression.

Authors:  Naomi Goldman; Yelizavet D Lomakova; Jennifer Londregan; Amanda Bucknum; Kelley DePierri; John Somerville; James E Riggs
Journal:  Cell Immunol       Date:  2017-12-30       Impact factor: 4.868

5.  The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors.

Authors:  Mukaddes Izci; Christy Maksoudian; Bella B Manshian; Stefaan J Soenen
Journal:  Chem Rev       Date:  2021-01-14       Impact factor: 60.622

6.  Angiogenesis and inflammation in invasive carcinoma of the breast.

Authors:  A H Lee; L C Happerfield; L G Bobrow; R R Millis
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

Review 7.  The role of ADAM17 in tumorigenesis and progression of breast cancer.

Authors:  Hongyu Shen; Liangpeng Li; Siying Zhou; Dandan Yu; Sujin Yang; Xiu Chen; Dandan Wang; Shanliang Zhong; Jianhua Zhao; Jinhai Tang
Journal:  Tumour Biol       Date:  2016-09-22

Review 8.  CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis.

Authors:  Jian Zhang; Lalit Patel; Kenneth J Pienta
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-14       Impact factor: 7.638

9.  Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancer.

Authors:  James L Murray; Patricia Thompson; Suk Young Yoo; Kim-Anh Do; Mala Pande; Renke Zhou; Yanhong Liu; Aysegul A Sahin; Melissa L Bondy; Abenaa M Brewster
Journal:  Breast Cancer Res Treat       Date:  2013-03-26       Impact factor: 4.872

10.  Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments.

Authors:  Kenneth J Pienta; Natalie McGregor; Robert Axelrod; David E Axelrod
Journal:  Transl Oncol       Date:  2008-12       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.